城市草坪温室气体排放特征及影响因素

草坪作为城市绿地的重要组成部分，其温室气体的吸收或排放不容忽视.然而当前对亚热带城市草坪温室气体通量的研究相对匮乏.采用静态箱-气相色谱法，对杭州市城区典型城市草坪的多种温室气体（CO₂、CH₄、N₂O和CO）地气交换通量进行了连续观测研究.结果表明，城市草坪的温室气体月平均通量变化明显，而其日变化特征并不明显.城市草地和土壤（无植被生长的裸土）是大气N₂O的源，平均通量分别为（0.66±0.17）μg·（m²·min）^-1和（0.58±0.20）μg·（m²·min）^-1；是CH₄和CO的汇，其中CH₄平均通量分别为（-0.21±0.078）μg·（m²·min）^-1和（-0.26±0.10）μg·（m²·min）^-1，CO分别为（-6.36±1.28）μg·（m²·min）^-1和（-6.55±1.69）μg·（m²·min）^-1.城市草地和土壤CO₂平均通量分别为（5.28±0.75） mg·（m²·min）^-1和（4.83±0.91） mg·（m²·min）^-1.基于相关性分析研究发现，草地和土壤的CO₂和N₂O通量均与降水量呈显著的负相关，而CH₄和CO通量与降水量呈显著的正相关；除草地CH₄通量与土壤温度无显著相关、草地N₂O通量与土壤温度呈显著负相关外，其余各温室气体通量与土壤温度均呈显著正相关.另外，城市草坪的草地和土壤CO₂（R²为0.371和0.314）和N₂O （R²为0.371和0.284）通量季节变化受降水量的影响要大于其它温室气体，而土壤温度对CO通量的影响（R²为0.290和0.234）要显著于其它温室气体.     

Carbon Dioxide Emission Reduction Scenarios in Mexico for Year 2005: Industrial Cogeneration and Efficient Lighting

An analysis of the impacts on Mexican energy demand and associated carbon dioxide (CO₂) emissions in the year 2005 due to efficient lighting in the commercial and residential sectors and cogeneration in the industrial sector is presented. Estimation of CO₂ abatement costs and an incremental cost curve for CO₂ mitigation options are considered. These technologies are cost effective opportunities, and together are projected to reduce CO₂ emissions in 2005 by nearly 13 percent. Implementation of efficient lighting is already part of the demand side management (DSM) programs of the Mexican state-owned utility. However, there are important barriers that may hinder the implementation of large scale cogeneration plants.     

Prenatal diagnosis of spinal muscular atrophy in Russia

Ninety-two families with spinal muscular atrophy (SMA) applied for genetic counselling and further prenatal diagnosis. To minimize expenses, only one tightly linked informative marker was determined in the course of preliminary examination, and non-radioactive allele detection was preferably used. Four prenatal diagnoses of SMA type I, four of SMA type II, and one of SMA type III were made. This trial programme shows the considerable requirements, importance, and potential effectiveness of prenatal prediction of SMA in Russia.     

Verification of carrier status for Becker muscular dystrophy from analysis of a blighted ovum

The polymerase chain reaction (PCR) was used on material from a blighted ovum to confirm indirectly the carrier status of a woman with a family history of Becker muscular dystrophy. Conventional testing including creatine kinase levels, muscle biopsy, and EMG had been inconclusive, and on the basis of one elevated creatine kinase level, the woman had been designated a possible carrier. Ultrasound examination at 10 weeks of pregnancy indicated a blighted ovum, from which DNA was subsequently extracted and subjected to PCR testing for determination of sex and genotypic status with respect to the known familial deletion of the dystrophin gene. The blighted ovum was found to have a Y chromosome and also to be deleted for at least exon 6 of the dystrophin gene, indirectly indicating that the mother most likely carried the family mutation for Becker muscular dystrophy.     

Prenatal diagnosis of Freeman–Sheldon syndrome (whistling face)

The diagnosis of Freeman–Sheldon syndrome was made by ultrasonographic evaluation of a 20-week fetus with a positive family history. The ultrasonographic features were abnormalities of the extremities and mouth.     

Extraction of DNA from amniotic fluid cells for the early prenatal diagnosis of genetic disease

Ten-ml samples of amniotic fluid were taken from pregnancies being terminated at 8–14 weeks' gestation. DNA was extracted from the amniotic cells by sequential centrifugation and analysed using the polymerase chain reaction (PCR). Fifteen samples were analysed for evidence of maternal contamination using Mfd5 oligo-nucleotide primers for repeat polymorphisms. Ten amniotic fluid samples were tested for the Delta-F₅₀₈ deletion characteristic of cystic fibrosis to demonstrate a diagnostic application for the technique. In each case, DNA extracted from fetal tissue from the same pregnancy was included in the controls. In 14 of the 15 cases tested with the Mfd5 primers, both the amniotic fluid DNA and the fetal DNA showed no evidence of contaminating DNA. In one case, neither the amniotic fluid cells nor the fetal cells yielded results. In nine of the ten cases tested with the Delta-F₅₀₈ primers, the amniotic fluid cell DNA provided accurate information about the genetic status of the fetus; in the tenth, the fetal DNA failed to amplify. The results indicate that adequate DNA can be extracted from amniotic fluid from 8 weeks' gestation onward and these samples are suitable for prenatal diagnosis using PCR.     

Prenatal screening and diagnosis of neural tube defects in England and Wales in 1985

A survey was carried out to determine the effect of prenatal screening and therapeutic abortion on births in 1985 with anencephaly and spina bifida in England and Wales. Maternal serum alpha-fetoprotein tests were done on 399 288 women (60 per cent of pregnant women): 4 per cent were reported as being screen-positive and 1 per cent had an amniocentesis. An estimated 534 pregnancies associated with anencephaly were terminated and an estimated 445 pregnancies associated with spina bifida (but without anencephaly) were terminated. Most (63 per cent) of the anencephalic pregnancies were first suspected from an ultrasound examination; 57 per cent of the spina bifida pregnancies were first suspected from a positive maternal serum alpha-fetoprotein test, 35 per cent by ultrasound, and the remaining 8 per cent by other means. The birth prevalence of anencephaly declined by 94 per cent between 1964–1972 and 1985, but when the terminations of pregnancy on account of having a fetus with anencephaly are added to the births the decline in prevalence was only 50 per cent. The birth prevalence of spina bifida declined by 68 per cent over the same period but when the terminations were added to the births the decline in prevalence was only 32 per cent. Among births with anencephaly 66 per cent had had no screening or diagnostic tests in early pregnancy, but in those that did nearly all were positive–usually in twin pregnancies where one fetus was affected but not the other. Among births with spina bifida, 48 per cent had no tests and in those that did the results were mainly negative. We conclude that in order to monitor adequately the national screening programme for anencephaly and spina bifida a special neural tube defects register should be formed.